lobbying_activities: 823034
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 823034 | f4cfb9c4-ad10-45da-b71e-e2da7059157c | Q3 | CAPITOL HILL CONSULTING GROUP | 72053 | ENDO PHARMACEUTICALS | 2009 | third_quarter | HCR | general Medicare and Medicaid issues, including but not limited to, coverage and reimbursement. General healthcare issues, including but not limited to, drug importation; Pharmaceutical Market Access Act (S.80); Prescription Drug Affordability Act (HR163); The Pharmaceutical Market Access and Drug Safety Act (S.525) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2009-10-06T14:44:34-04:00 |